ANTENGENE-B (06996) Shareholders Deposit Shares into Standard Chartered Bank (Hong Kong) with Market Value of HK$416 Million

Stock News
08/19

According to the latest data from the Hong Kong Stock Exchange, on August 18, shareholders of ANTENGENE-B (06996) deposited shares into Standard Chartered Bank (Hong Kong), with a deposited market value of HK$416 million, representing 9.23% of the company's shares. On July 28, ANTENGENE announced that China's National Medical Products Administration (NMPA) has approved Selinexor (in combination with bortezomib and dexamethasone (XVd)) for the treatment of adult patients with multiple myeloma (MM) who have received at least one prior therapy. This represents a new indication for Selinexor.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10